Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
GW441756
i
Other names:
GW441756
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Kanazawa Medical University
Drug class:
TrkA receptor inhibitor
Related drugs:
‹
larotrectinib (189)
entrectinib (178)
KRC-108 (1)
DCC-2701 (0)
PBI-200 (0)
larotrectinib (189)
entrectinib (178)
KRC-108 (1)
DCC-2701 (0)
PBI-200 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
TPM3-NTRK1 fusion
Colorectal Cancer
TPM3-NTRK1 fusion
Colorectal Cancer
GW441756
Sensitive: D – Preclinical
GW441756
Sensitive
:
D
GW441756
Sensitive: D – Preclinical
GW441756
Sensitive
:
D
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.